These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21993215)

  • 1. STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive men.
    Donner KM; Hiltunen TP; Hannila-Handelberg T; Suonsyrjä T; Kontula K
    Hypertens Res; 2012 Jan; 35(1):107-14. PubMed ID: 21993215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
    Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Donner K; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Kontula K; Hiltunen TP
    J Hypertens; 2008 Jun; 26(6):1250-6. PubMed ID: 18475165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.
    Donner KM; Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Tikkanen I; Antikainen M; Hirvonen A; Kontula K
    J Hypertens; 2009 Oct; 27(10):2001-9. PubMed ID: 19593208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men.
    Porthan K; Viitasalo M; Hiltunen TP; Vaananen H; Dabek J; Suonsyrja T; Hannila-Handelberg T; Virolainen J; Nieminen MS; Toivonen L; Kontula K; Oikarinen L
    Ann Med; 2009; 41(1):29-37. PubMed ID: 18608135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma fibrin clot properties in arterial hypertension and their modification by antihypertensive medication.
    Rajzer M; Wojciechowska W; Kawecka-Jaszcz K; Undas A
    Thromb Res; 2012 Jul; 130(1):99-103. PubMed ID: 21917299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular approaches to individualize antihypertensive drug therapy.
    Hiltunen TP; Kontula K
    Ann Med; 2012 Jun; 44 Suppl 1():S23-9. PubMed ID: 22713145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
    Hiltunen TP; Donner KM; Sarin AP; Saarela J; Ripatti S; Chapman AB; Gums JG; Gong Y; Cooper-DeHoff RM; Frau F; Glorioso V; Zaninello R; Salvi E; Glorioso N; Boerwinkle E; Turner ST; Johnson JA; Kontula KK
    J Am Heart Assoc; 2015 Jan; 4(1):e001521. PubMed ID: 25622599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES study.
    Suonsyrjä T; Hannila-Handelberg T; Fodstad H; Donner K; Kontula K; Hiltunen TP
    Am J Hypertens; 2009 Feb; 22(2):169-75. PubMed ID: 19057513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of CYP11B2 gene -344T/C polymorphism on renin-angiotensin-aldosterone system activity and blood pressure response to hydrochlorothiazide].
    Li Y; Yang P; Wu SL; Yuan JX; Wu Y; Zhao DD; Xu S; Zhao LP; Sun MJ; Chu LM; Lu DS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):68-71. PubMed ID: 22311496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
    Wilson TW; Lacourcière Y; Barnes CC
    CMAJ; 1998 Sep; 159(5):469-76. PubMed ID: 9757170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renin-angiotensin-aldosterone system gene polymorphisms on blood pressure response to antihypertensive treatment.
    Jiang X; Sheng HH; Lin G; Li J; Lu XZ; Cheng YL; Huang J; Xiao HS; Zhan YY
    Chin Med J (Engl); 2007 May; 120(9):782-6. PubMed ID: 17531119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats.
    Hohl M; Lauder L; Sevimli Ö; Tokcan M; Wagmann L; Götzinger F; Schneider C; Hübner U; Lehnert U; Meyer MR; Böhm M; Mahfoud F
    Hypertension; 2023 Jun; 80(6):e90-e100. PubMed ID: 36999443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of losartan plus hydrochlorothiazide on nitric oxide status in 'nondipper' hypertensive patients.
    Cammarata R; Armas-Hernández MJ; Hernández-Hernández R; Armas-Padilla MC; Sosa-Canache B; Pacheco B; Guerrero J; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):161-5. PubMed ID: 17414584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and medication during long-term antihypertensive therapy based on morning home SBP in hypertensive patients: Hypertension Control Based on Home Systolic Pressure (HOSP) substudy.
    Kawano Y; Horio T; Kamide K; Iwashima Y; Yoshihara F; Nakamura S
    Clin Exp Hypertens; 2010 Jul; 32(4):239-43. PubMed ID: 20608895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.